, Tracking Stock Market Picks
Enter Symbol:
Penwest Pharmaceuticals Co. (PPCO) [hlAlert]

down 58.36 %

Penwest Pharmaceuticals Co. (PPCO) rated Buy

Posted on: Friday,  Dec 14, 2007  8:25 AM ET by Broadpoint Capital

Broadpoint Capital rated Buy Penwest Pharmaceuticals Co. (NASDAQ: PPCO) on 12/14/2007, when the stock price was $6.22. Since
then, Penwest Pharmaceuticals Co. has lost 58.36% as of 11/03/2010's recent price of $2.59.
If you would have followed this Broadpoint Capital's recommendation on PPCO, you would have lost 58.36% of your investment in 1055 days.

Penwest Pharmaceuticals Co. (Penwest) is a drug development company focused on identifying and developing products that address unmet medical needs, primarily for rare disorders of the nervous system. The Company is developing A0001, a coenzyme Q analog drug candidate that it licensed from Edison Pharmaceuticals, Inc. (Edison), for inherited mitochondrial respiratory chain diseases. The Company is also applying its drug delivery technologies and drug formulation expertise to the formulation of product candidates under licensing collaborations, referred to as drug delivery technology collaborations.

Broadpoint Capital, Inc. is an investment banking and capital markets firm that provides corporate and public finance services and trading of corporate, government, and municipal securities for institutions. The company has three divisions: Municipal Capital Markets division, which underwrites and trades municipal securities in new issue and secondary markets; Taxable Fixed Income division, which is a dealer focusing on fixed income securities with limited liquidity; and Equity Capital Markets division, which is a sector-focused investment banking group providing research, trading, raising of capital and advisory services for institutional and corporate clients. Broadpoint Capital, formerly known as First Albany Corporation, was founded in 1953 and is based in New York, New York. The company operates as a subsidiary of First Albany Companies Inc.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/14/2007 8:25 AM Buy
6.22 10.25
as of 8/27/2015
1 Week   
1 Month   
3 Months   
1 YTD up  31.57 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy